Photodynamic therapy of subfoveal neovascular membrane in type 2A idiopathic juxtafoveolar retinal telangiectasis-Reference-Cited by-同舟云学术

Photodynamic therapy of subfoveal neovascular membrane in type 2A idiopathic juxtafoveolar retinal telangiectasis

Published:2004-05 Issue:5 Volume:137 Page:812-819
ISSN:0002-9394
Container-title:American Journal of Ophthalmology
language:en
Short-container-title:American Journal of Ophthalmology

Author:

Snyers Bernadette,Verougstraete Claire,Postelmans Laurence,Leys Anita,Hykin Philip

Publisher

Elsevier BV

Subject

Ophthalmology

Reference11 articles.

1. Idiopathic juxtafoveolar retinal telangiectasis. Update of classification and follow-up study;Gass;Ophthalmology,1993

2. Gass JDM. Retinal capillary diseases. In: Stereoscopic atlas of macular diseases. 4th ed. St Louis: Mosby; 1997:506–510

3. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin. One-year results of two randomized clinical trials—TAP Report 1;Arch Ophthalmol,1999

4. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin. Two-year results of two andomized clinical trials—TAP Report 2;Arch Ophthalmol,2001

5. A preliminary study of photodynamic therapy using verteporfin for choroidal neovascularization in pathologic myopia, ocular histoplasmosis syndrome, angioid streaks, and idiopathic causes;Sickenberg;Arch Ophthalmol,2000

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-Term Outcomes in Macular Telangiectasia Type 2 With Subretinal Neovascularization;Journal of VitreoRetinal Diseases;2020-06-17

2. Subretinal Neovascularization Associated with Idiopathic Juxtafoveal Telangiectasia;Choroidal Neovascularization;2020

3. Retinal and Choroidal Vascular Diseases;Current Practices in Ophthalmology;2018

4. Intravitreal anti-VEGF treatment for subretinal neovascularisation secondary to type 2 idiopathic juxtafoveolar telangiectasia;International Ophthalmology;2017-01-21

5. Intravitreal Bevacizumab Treatment in Type 2 Idiopathic Macular Telangiectasia;Türk Oftalmoloji Dergisi;2016-12-01